C&C Group Valuation

Is CGPZ.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CGPZ.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CGPZ.F ($1.95) is trading above our estimate of fair value ($1.7)

Significantly Below Fair Value: CGPZ.F is trading above our estimate of fair value.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CGPZ.F?

Key metric: As CGPZ.F is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for CGPZ.F. This is calculated by dividing CGPZ.F's market cap by their current revenue.
What is CGPZ.F's PS Ratio?
PS Ratio0.4x
Sales€1.65b
Market Cap€675.15m

Price to Sales Ratio vs Peers

How does CGPZ.F's PS Ratio compare to its peers?

The above table shows the PS ratio for CGPZ.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average3x
MGPI MGP Ingredients
1.3x-7.6%US$1.0b
NAPA Duckhorn Portfolio
4x8.3%US$1.6b
CWGL Crimson Wine Group
1.9xn/aUS$138.5m
BF.B Brown-Forman
4.8x4.6%US$20.0b
CGPZ.F C&C Group
0.4x4.2%US$562.9m

Price-To-Sales vs Peers: CGPZ.F is good value based on its Price-To-Sales Ratio (0.4x) compared to the peer average (3x).


Price to Sales Ratio vs Industry

How does CGPZ.F's PS Ratio compare vs other companies in the US Beverage Industry?

7 CompaniesPrice / SalesEstimated GrowthMarket Cap
EAST Eastside Distilling
0.3xn/aUS$3.14m
WTER Alkaline Water
0.01xn/aUS$613.31k
CIRX CirTran
0.08xn/aUS$98.91k
VWES.Q Vintage Wine Estates
0.0003xn/aUS$89.91k
CGPZ.F 0.4xIndustry Avg. 2.9xNo. of Companies7PS01.63.24.86.48+
7 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: CGPZ.F is good value based on its Price-To-Sales Ratio (0.4x) compared to the US Beverage industry average (2.9x).


Price to Sales Ratio vs Fair Ratio

What is CGPZ.F's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CGPZ.F PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.4x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CGPZ.F's Price-To-Sales Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CGPZ.F forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$1.95
US$2.62
+34.1%
24.9%US$3.91US$2.15n/a5
Nov ’25US$1.97
US$2.62
+32.7%
24.9%US$3.91US$2.15n/a5
Oct ’25US$2.18
US$2.61
+19.9%
25.1%US$3.92US$2.16n/a5
Sep ’25n/a
US$2.64
0%
23.9%US$3.86US$2.13n/a5
Aug ’25US$1.95
US$2.63
+34.8%
22.7%US$3.79US$2.09n/a5
Jul ’25n/a
US$2.63
0%
22.8%US$3.79US$2.09n/a5
Jun ’25n/a
US$2.56
0%
25.0%US$3.76US$1.82n/a5
May ’25n/a
US$2.55
0%
25.2%US$3.74US$1.80n/a5
Apr ’25n/a
US$2.60
0%
25.3%US$3.83US$1.84n/a5
Mar ’25US$1.83
US$2.58
+40.8%
25.3%US$3.79US$1.83n/a5
Feb ’25US$2.05
US$2.58
+26.1%
25.5%US$3.82US$1.84n/a5
Jan ’25n/a
US$2.45
0%
29.0%US$3.79US$1.75n/a5
Dec ’24US$1.72
US$2.38
+38.4%
28.7%US$3.66US$1.71n/a5
Nov ’24n/a
US$2.53
0%
26.0%US$3.64US$2.00US$1.974
Oct ’24n/a
US$2.58
0%
26.1%US$3.71US$2.04US$2.184
Sep ’24US$1.80
US$2.72
+51.4%
26.5%US$3.94US$2.17n/a4
Aug ’24n/a
US$2.72
0%
26.5%US$3.94US$2.17US$1.954
Jul ’24US$1.59
US$2.57
+62.0%
25.9%US$3.69US$2.03n/a4
Jun ’24n/a
US$2.57
0%
25.9%US$3.69US$2.03n/a4
May ’24n/a
US$2.38
0%
2.6%US$2.47US$2.33n/a3
Apr ’24US$1.80
US$2.38
+32.7%
2.6%US$2.47US$2.33n/a3
Mar ’24US$1.80
US$2.75
+52.6%
17.2%US$3.53US$2.33US$1.834
Feb ’24US$2.00
US$2.75
+37.3%
17.2%US$3.53US$2.33US$2.054
Jan ’24n/a
US$2.96
0%
12.5%US$3.47US$2.50n/a4
Dec ’23n/a
US$2.96
0%
12.5%US$3.47US$2.50US$1.724
Nov ’23n/a
US$2.84
0%
12.3%US$3.31US$2.39n/a4

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies